PROSTAGLANDIN
MOLECULAR TARGETProstaglandin G/H synthase 1 (human)
PROSTAGLANDIN (Prostaglandin G/H synthase 1 (human)) is targeted by 14 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PROSTAGLANDIN
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Celecoxib | 2.48 | 11 |
| 2 | Dinoprostone | 1.39 | 3 |
| 3 | Etodolac | 1.10 | 2 |
| 4 | Indomethacin | 1.10 | 2 |
| 5 | Meloxicam | 1.10 | 2 |
| 6 | Niflumic Acid | 1.10 | 2 |
| 7 | sulindac sulfide | 1.10 | 2 |
| 8 | Naproxen | 0.69 | 1 |
| 9 | Resveratrol | 0.69 | 1 |
| 10 | Artemether | 0.69 | 1 |
| 11 | felbinac | 0.69 | 1 |
| 12 | Hexachlorophene | 0.69 | 1 |
| 13 | Oxaprozin | 0.69 | 1 |
| 14 | Tolmetin | 0.69 | 1 |
About PROSTAGLANDIN as a Drug Target
PROSTAGLANDIN (Prostaglandin G/H synthase 1 (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 14 compounds with documented PROSTAGLANDIN interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PROSTAGLANDIN inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.